Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): a Randomized, Double-Blind, Placebo-Controlled Trial. Gathe JC, Dejesus E, Ramgopal MN, Rolle CP, et al. J Acquir Immune Defic Syndr 2025 Feb 20. doi: 10.1097/QAI.0000000000003648.

Read + Share

Amedeo Smart

Independent Medical Education

Gathe JC, Dejesus E, Ramgopal MN, Rolle CP, et al. Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): a Randomized, Double-Blind, Placebo-Controlled Trial. J Acquir Immune Defic Syndr 2025 Feb 20. doi: 10.1097/QAI.0000000000003648.
PMID: 39972543